Heart Failure
Surfaces untreated and undertreated HF patients before decompensation occurs.
47 algorithms · 20,588 patients · $24.1M opportunity
Find the cardiac patients falling through the cracks
TAILRD is an AI platform that scans your EHR data to identify cardiovascular patients with unmet clinical needs — across six disease areas simultaneously.
Co-developed with Mount Sinai — the #2-ranked cardiac hospital in the U.S. 780+ gap-detection algorithms, EHR-native via Redox, deployed in production.
20,588
patients with detected care gaps
Heart Failure module — live gap detection
The opportunity
Therapy gaps are measurable — and fixable
Cardiovascular patients remain dramatically undertreated despite proven guideline-directed therapies — and every gap carries both a clinical and a financial cost. Below: published undertreatment rates, paired with the estimated annual opportunity for a 400-bed program.
Heart Failure
<1%
Patients on optimal GDMT dosesCHAMP-HF Registry
$2.8M
readmission penalty avoidance
- 340 patients eligible for GDMT optimization
- 185 avoidable readmissions
Electrophysiology
68%
AFib patients under-anticoagulated before strokeStroke Unit Studies
$4.1M
LAAC/ablation procedure opportunity
- 210 undetected AFib patients
- 143 anticoagulation gaps
Structural Heart
40%
Severe aortic stenosis patients remain untreatedEur Heart J, 2024
$4.2M
procedure revenue opportunity
- 85 unscheduled TAVR candidates
- 52 severe AS patients without referral
Coronary
42%
CAD patients not on guideline-recommended statinsMEPS, AHRQ
$3.4M
revascularization opportunity
- 180 patients needing Heart Team review
- 156 critical safety patients
Valvular
8.2%
VHD prevalence in older adults — mostly undiagnosedOxVALVE Study
$1.8M
surgical planning opportunity
- 1,240 patients needing surveillance
- 680 untracked post-procedure patients
Peripheral Vascular
44%
PAD diagnosed only after specialist referralPARTNERS Program
$2.4M
intervention opportunity
- 280 ABI screening gaps
- 48 critical limb ischemia patients
Clinical rates from CHAMP-HF, OxVALVE, PARTNERS, and MEPS registries and published society data (ACC, AHA, Eur Heart J). Financial estimates apply CMS reimbursement benchmarks to a 400-bed program. Actual results vary by patient population and program maturity.
The difference
Why health systems choose TAILRD
Most cardiac AI tools solve a narrow problem. TAILRD was built to see the entire system.
Full-Continuum Intelligence
Unlike point solutions, TAILRD analyzes the entire cardiovascular journey — from early risk identification to advanced intervention — continuously, not episodically.
Therapy-Gap Detection
TAILRD doesn't just identify disease. It flags patients who should already be receiving care — but aren't.
Clinically Grounded AI
Every insight is anchored in guidelines, real-world data, and validated clinical pathways — not black-box predictions.
Operationally Actionable
Insights route to the right stakeholder — clinicians, service line leaders, and executives — in formats designed for action, not dashboards.
Care continuum
Gaps span the entire care journey
TAILRD continuously scans every stage of the cardiovascular continuum — not just the moment of intervention. Therapy gaps emerge long before patients reach specialty care. TAILRD identifies them early, and keeps tracking them until care is delivered.
1
Upstream Risk Capture
Primary care identification
2
Screening & Triage
Diagnostic workup + routing
3
Medical Management
Guideline therapy optimization
4
Device Therapy
ICD · CRT · pacing
5
Procedural Intervention
PCI · TAVR · ablation · SAVR
6
Advanced Therapies
LVAD · transplant
The platform
Six clinical modules + Research Assist. One integrated platform.
Each module detects therapy gaps, flags missed interventions, and routes prioritized worklists to the right team.
Electrophysiology
Identifies rhythm patients who meet criteria for anticoagulation, monitoring, or intervention.
1,730 patients · LAAC · CSP/CRT · Dofetilide REMS
Structural Heart
Flags echo findings, referral gaps, and delayed interventions across structural disease.
1,814 patients · 24 active gaps · $10.8M opportunity
Coronary Revascularization
Detects missed opportunities in CAD risk stratification, diagnosis, and escalation of care.
2,330 patients · 26 auto-detected gaps · CABG vs PCI support
Valvular Surgery
Surfaces progressive valve disease earlier — when intervention can still change outcomes.
1,784 patients · Echo → Cath → Surgery coordination
Peripheral Vascular
Expands PAD detection, closes therapy gaps, and identifies limb-preservation candidates.
1,150 patients · ABI · AAA · TCAR · VTE
Clinical Research Assist
Automates registry abstraction and trial eligibility screening from live clinical data.
80% auto-fill · 212 abstraction hours saved / month
Built for every role
Intelligence at every level
The same gap intelligence, surfaced differently for each person who acts on it.
For leadership
Executive
Command center across all six modules — clinical gap intelligence, quality benchmarking, financial performance, and competitive market intelligence.
Example: Undiagnosed HFpEF, untreated AF, silent structural disease
For service-line directors
Service Line
AI-detected insights, care-gap analysis, revenue pipeline, and margin-improvement opportunities by module.
Example: Patients eligible for GDMT, anticoagulation, or referral
For clinicians
Care Team
Patient-level gap worklists, safety alerts, recommended actions, and one-click referral.
Example: Referral, imaging, procedure, or therapy initiation
Trust & compliance
Built for Health System Procurement
Data Architecture
All processing occurs within your network boundary via Redox. No PHI stored on TAILRD infrastructure. EHR-native deployment.
SOC 2 & HITRUST
TAILRD runs on Aptible's HITRUST CSF certified, SOC 2 audited infrastructure, inheriting its platform-level security and compliance controls. TAILRD's own company-level SOC 2 Type II certification is in progress; documentation available under NDA.
Deployment Model
Deployed on AWS through Aptible's HITRUST-certified managed platform — containers, managed PostgreSQL, and networking are handled by Aptible, so TAILRD inherits compliant infrastructure without operating its own. No on-premise installation required.
Integration
Redox-certified integration layer. Compatible with Epic, Cerner, Meditech, and all major EHR platforms. Live in days.
Validation
Recognition & Partners
Recognition
2026 Accelerator Cohort · Top 4% of 1,835 applicants
Elementa Labs — health tech incubator, 13th company accepted
Health System Partners
Cardiovascular co-development partner
Technology Partners
Leadership
Jonathan Hart
CEO & Founder
20+ years cardiovascular industry · Faculty: ACC, TCT, AVAM · Named to Cardiovascular Business 40 Under 40.
Dr. Tony Das
Chief Medical Officer
Interventional cardiologist, Harvard/MGH trained. VIVA founding member. 20,000+ procedures.
Božidar Benko
Chief Technology Officer
Employee #1 at VuMedi. Healthcare AI specialist. Expert in scalable EHR data infrastructure.
Getting started
From zero data to actionable gaps in weeks
1
Free Program Analytics
We analyze your cardiovascular program using CMS benchmark data. No PHI. No EHR connection. Your estimated gap opportunity identified in ~2 weeks.
2
See Your Opportunity
Receive a prioritized report of clinical and financial gaps across your patient population — specific to your program size, payer mix, and service lines.
3
Connect Your EHR
Native Redox integration brings real patient-level data into TAILRD. No PHI leaves your environment. Live in days, not months.
4
Your Teams Take Action
Prioritized worklists delivered to physicians, service line leaders, and registries. Every gap tracked to closure.
Start with a Free Program Analytics Report
We'll analyze your cardiovascular program using CMS benchmark data and identify your estimated gap opportunity.